GTV delineating for patients with postoperative glioma based on enhanced T2-FLAIR sequence instead of enhanced T1-TFE sequence: a feasibility study
The volume of GTV delineated by T2-FLAIR+C was slightly larger compared to that by T1-TFE+C, and T2-FLAIR+C could provide a more comprehensive range of GTV delineation. CR was statistically significant between the two groups (P < 0.05), and T2-FLAIR+C demonstrated the ability to accurately depict changes in tumor boundaries and surrounding edema with a higher tumor enhancement signal. Therefore, GTV delineation of gliomas based on T2-FLAIR+C may offer certain advantages and could potentially serve as a complete replacement for T1-TFE+C in future clinical applications.
Authors
- Hongwei� Jiang (ORCID: https://orcid.org/0000-0003-3807-7989)
- Yuanyuan Li (ORCID: https://orcid.org/0000-0003-2326-8950)
- Xingru Sun
- Yin Zhang (ORCID: https://orcid.org/0000-0002-6761-2269)
- Qingqing Yuan (ORCID: https://orcid.org/0000-0002-0454-9960)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-25
- DOI
- https://doi.org/10.1007/s12672-025-02697-8
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanming Project of Medicine in Shenzhen